Position in NKTR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,008,392
+$2,965,222 QoQ
Shares Held
43,094
+7082.3% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 239 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. NKTR ranks #73 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in NKTR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,008,392 | 43,094 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $43,170 | 600 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,228 | 100 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,690 | 100 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $150,797 | 221,761 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $167,226 | 179,813 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $238,082 | 183,140 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $229,543 | 185,116 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,951 | 5,324 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,981 | 5,324 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,194 | 5,324 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $8,144 | 14,043 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $432,338 | 617,626 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,303,766 | 576,888 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,823,484 | 569,839 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,102,346 | 553,249 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,381,145 | 441,771 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,845,520 | 432,681 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,584,790 | 477,995 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,461,184 | 493,076 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $9,968,500 | 498,425 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $8,457,789 | 497,517 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $7,934,748 | 478,285 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $11,336,194 | 489,473 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,407,974 | 471,035 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||